November 17, 2009

Medicis Pharmaceutical Corporation v. Lupin Ltd. et al

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. July 25, 2011

    Lupin, Medicis Reach Deal Over Generic Solodyn

    Lupin Ltd. said Monday it had reached a deal with Medicis Pharmaceutical Corp. to make a generic version of the acne drug Solodyn and to start a development collaboration worth an initial $20 million, resolving patent litigation in Maryland federal court.

1 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!